Tri-Moxi+¿ recall (Imprimis NJOF, LLC)
DrugClass IIOngoing
Summary: Imprimis NJOF, LLC is recalling Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.. Reason: Presence of particulate matter - Glass like particles.
What is being recalled
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Why
Presence of particulate matter - Glass like particles.
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
U.S Nationwide
How to tell if yours is affected
Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0251-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | December 18, 2025 |
| Reported | January 14, 2026 |
| Company | Imprimis NJOF, LLC |
| Company location | Ledgewood, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 314 boxes of 6,280 pre-filled syringes |
More recalls from Imprimis NJOF, LLC · all drug recalls · recalls from December 2025